Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes
Elaine Ku, Mark J. Sarnak(Tufts Medical Center), Barbara Grimes(University of California, San Francisco), Franz Schaefer(Heidelberg University), Lesley A. Inker(Tufts Medical Center), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Piero Ruggenenti(Mario Negri Institute for Pharmacological Research), Hocine Tighiouart(Tufts University), Elke Wühl(Heidelberg University), Charles E. McCulloch(University of California, San Francisco)
Cited by 33
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
|New England Journal of Medicine|2012|4.1k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
Non-Transgenic Mouse Models of Kidney Disease
|The Nephron journals/Nephron journals|2016|1.9k